BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/20/2025 2:39:06 AM | Browse: 30 | Download: 77
 |
Received |
|
2024-09-03 02:19 |
 |
Peer-Review Started |
|
2024-09-03 02:19 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2024-11-21 07:25 |
 |
Revised |
|
2024-11-24 15:05 |
 |
Second Decision |
|
2024-12-16 02:46 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-12-16 08:19 |
 |
Articles in Press |
|
2024-12-16 08:19 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2024-12-30 04:10 |
 |
Publish the Manuscript Online |
|
2025-01-20 02:39 |
ISSN |
1948-0210 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Respiratory System |
Manuscript Type |
Letter to the Editor |
Article Title |
Microvesicles derived from mesenchymal stem cells: A promising therapeutic strategy for acute respiratory distress syndrome-related pulmonary fibrosis?
|
Manuscript Source |
Invited Manuscript |
All Author List |
Zhao Zhang, Xin-Yun Shan, Ce Liang, Lan Zhao and Xiao-Qian Shan |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
National Natural Science Foundation of China |
82174442 |
|
Corresponding Author |
Lan Zhao, MD, PhD, Professor, Tianjin Institute of Acupuncture and Moxibustion, The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, No. 88 Changling Road, Xiqing District, Tianjin 300381, China. lanzhao69@163.com |
Key Words |
Microvesicles derived from mesenchymal stem cells; Acute respiratory distress syndrome; Pulmonary fibrosis; Hepatocyte growth factor; Mesenchymal stromal cells |
Core Tip |
Pulmonary fibrosis serves as a critical predictor of adverse outcomes in patients with acute respiratory distress syndrome. Currently, effective treatments for pulmonary fibrosis are notably scarce in clinical settings, highlighting the need for the identification of safe and effective therapeutic strategies. This study supports the Chen et al’s conclusion. To deepen our understanding of this novel therapeutic option, we initially review the safety and efficacy of mesenchymal stem cells therapy. Subsequently, we elaborate on the potential applications and challenges associated with mesenchymal stem cells-microvesicles as an emerging therapeutic modality. |
Publish Date |
2025-01-20 02:39 |
Citation |
<p>Zhang Z, Shan XY, Liang C, Zhao L, Shan XQ. Microvesicles derived from mesenchymal stem cells: A promising therapeutic strategy for acute respiratory distress syndrome-related pulmonary fibrosis? <i>World J Stem Cells</i> 2025; 17(1): 101036</p> |
URL |
https://www.wjgnet.com/1948-0210/full/v17/i1/101036.htm |
DOI |
https://dx.doi.org/10.4252/wjsc.v17.i1.101036 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345